Medical News

RSS

Oxygen delivered through the nose may improve poor vision caused by diabetic macular edema

In a study of five diabetic patients with persistent macular edema, breathing supplemental oxygen for three months reduced fluid buildup and swelling in the macula and, in some cases, improved visual acuity. Researchers think the therapy could be used in conjunction with laser treatments that also improve oxygenation in the retina to provide long-term stability in these patients.

20 May 2004

Dietary supplement reduces body fat mass in overweight adults by as much as nine percent

A study to be published in the June issue of The American Journal of Clinical Nutrition concludes that the dietary supplement, conjugated linoleic acid (CLA), reduces body fat mass in overweight, but otherwise healthy, adults by as much as nine percent.

20 May 2004

Study has important implications for African Americans who suffer from high blood pressure

A new study has important implications for the millions of African Americans who suffer from high blood pressure. The study, AADVANCE, shows Diovan HCT(R) (valsartan and hydrochlorothiazide) lowers blood pressure in African Americans to aggressive recommended target blood pressure goals as effectively as amlodipine.

20 May 2004

Scientists have taken the first steps towards producing a sustainable and pure source of the healthy fats found in oily fish

Eating such fish is encouraged as part of a healthy diet as their oils are rich in very long chain polyunsaturated fatty acids (VLCPUFAs). However, views on the health-promoting nature of VLCPUFAs have to be balanced against the marine pollution that can cause fish, and the oils extracted from them, to be contaminated with heavy metals and dioxins, and the fact that fish stocks are in global decline.

20 May 2004

UK pet owners who take their animals on holiday to Europe could bring back tropical diseases

UK pet owners who take their animals on holiday to Europe are being alerted to the fact that their pets could bring back some unwelcome souvenirs in the form of diseases more often associated with the tropics.

20 May 2004

Watching for West Nile virus, dead bird and mosquito monitoring resumes

Warmer spring weather and the coming mosquito season has the Department of Health on the lookout for West Nile virus again, working with local health departments to identify mosquitoes, track dead birds and monitor any human illness across Washington. This season brings mosquito-breeding weather and the threat of mosquito-borne disease, including West Nile virus.

20 May 2004

Bone repair using breakthrough material

A breakthrough in polymer development means that soon there may be a radical new treatment for people with broken bones - a special kind of material that can 'glue' the bone back together and support it while it heals. The polmer material is designed to break down as the bone regrows leaving only natural tissue.

20 May 2004

Australian government puts it on the record that prices of prescription medicines will not rise as a result of the Free Trade Agreement with the United States

The price of prescription medicines will not rise as a result of the Free Trade Agreement with the United States. The Australian Government gave this undertaking going into the negotiations and has delivered on this commitment.

20 May 2004

Causes of hepatitis and potential therapies that may improve care presented in study

Hepatitis, a potentially serious disease caused by a virus that attacks the liver, is a major problem worldwide. Hepatitis A is generally food-borne, while hepatitis B and C spread primarily through parenteral or sexual routes. Hepatitis B and C can be life-long, potentially deadly chronic infections.

19 May 2004

Accurate and effective new methods for diagnosis of Inflammatory bowel diseases

Inflammatory bowel diseases collectively cause significant lifestyle sacrifices and suffering and millions of dollars in related health care costs every year, partially due to a lack of effective diagnostic procedures and therapies. In new studies presented today at Digestive Disease Week in New Orleans, researchers show evidence of accurate and effective new methods for diagnosis, as well as improved treatment options, for sufferers of ulcerative colitis and Crohn’s diseases.

19 May 2004

Studies identify risk factors for colon cancer in women

In new studies presented today at Digestive Disease Week in New Orleans, scientists report that women’s preferences for a female physician may delay or prevent proper colorectal screenings due to a lack of females in the field and diabetes may be a significant risk factor for development of colon cancer.

19 May 2004

Caffeinated beverages may benefit some people who are at high-risk for liver disease

According to new research presented today at Digestive Disease Week, drinking caffeinated beverages may benefit some people who are at high-risk for liver disease. Conversely, a study by researchers from India found that soda drinkers, who represent a huge percentage of the American population, may actually have an increased risk of developing esophageal cancer.

19 May 2004

Dental appliance may help weight loss

Many Americans eat so fast, there isn't time to feel full until we realize we've overdone it. So we keep on eating, consuming more calories than we need. Now, there is an innovative appliance helps accomplish what our mothers always told us -- slow down, take smaller bites, and chew our food longer. Unlike many approaches to diets, this appliance is focused not on what we eat -- but how we eat.

19 May 2004

CRT implantable defibrillators significantly reduce hospitalization rates and extend lives

Researchers at the University of Colorado Health Sciences Center have announced the findings of a large-scale clinical trial for patients with late-stage heart failure. Results showed that cardiac resynchronization therapy (CRT) from implantable pacemaker-like devices or CRT combined with an implantable defibrillator (CRT-D), when used in addition to optimal drug therapy, reduced significantly the mortality and first hospitalization rate when compared to drug therapy alone. CRT-D also substantially lowered mortality.

19 May 2004

HHS creates task force to encourage medical technology innovation

HHS Secretary Tommy G. Thompson has announced that the department is forming an internal task force to weigh new ideas and promote new solutions to encourage innovation in health care and to speed the development of effective new medical technologies, such as drug and biological products and medical devices.

19 May 2004

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation and survive can expect full recovery to take 3-5 years

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation (HCT) and survive can expect full recovery to take 3-5 years, according to a study published in the May 19 issue of The Journal of the American Medical Association (JAMA).

19 May 2004

New study of tumor genetics may help to treat patients with head and neck cancer

Head and neck tumors account for more than 40,000 new cancers annually in the United States. The most common of these is squamous cell carcinoma. Prognosis is based largely on location and size of the tumor, and if the cancer has spread, or metastasized, to lymph nodes and distant sites in the body.

19 May 2004

Network formed to tackle potentially fatal reaction to smallpox vaccine

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), launched the Atopic Dermatitis and Vaccinia Network (ADVN), a nationwide research group that seeks to reduce the risk of eczema vaccinatum (EV), a severe and potentially deadly complication of smallpox immunization.

19 May 2004

$First drug approved for hormone refractory prostate cancer that has shown a survival benefit$

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

19 May 2004

FDA approves new drug for bone marrow disease

The Food and Drug Administration (FDA) today announced the approval of Vidaza (azacitidine) injection, the first effective treatment for patients with Myelodysplastic Syndrome (MDS). The product was given Fast Track Status and a priority review.

19 May 2004

Medical News

Oxygen delivered through the nose may improve poor vision caused by diabetic macular edema

Dietary supplement reduces body fat mass in overweight adults by as much as nine percent

Study has important implications for African Americans who suffer from high blood pressure

Scientists have taken the first steps towards producing a sustainable and pure source of the healthy fats found in oily fish

UK pet owners who take their animals on holiday to Europe could bring back tropical diseases

Watching for West Nile virus, dead bird and mosquito monitoring resumes

Bone repair using breakthrough material

Australian government puts it on the record that prices of prescription medicines will not rise as a result of the Free Trade Agreement with the United States

Causes of hepatitis and potential therapies that may improve care presented in study

Accurate and effective new methods for diagnosis of Inflammatory bowel diseases

Studies identify risk factors for colon cancer in women

Caffeinated beverages may benefit some people who are at high-risk for liver disease

Dental appliance may help weight loss

CRT implantable defibrillators significantly reduce hospitalization rates and extend lives

HHS creates task force to encourage medical technology innovation

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation and survive can expect full recovery to take 3-5 years

New study of tumor genetics may help to treat patients with head and neck cancer

Network formed to tackle potentially fatal reaction to smallpox vaccine

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

FDA approves new drug for bone marrow disease

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News